Vanscoy Rare
Overview
Independent rare disease pharmacy launched in 2024 by the founders of PANTHERx Rare (led by Gordon Vanscoy), offering exclusive distribution and a proprietary AI-integrated patient care management platform (V-IMPACT) for rare therapy launches.
Notable
Founding team created the first URAC Rare Pharmacy accreditation standards; explicitly markets independence from private equity ownership.
Key services
- exclusive rare disease distribution
- patient care management platform
- manufacturer launch services
Subcategories
Verified Reviews
No verified reviews yet — are you a customer of Vanscoy Rare? Share your experience in a short, confidential interview.
Share your experience